Growing evidence suggests an involvement of the endothelin B receptor (ETB-R) in blood pressure-dependent arterial remodeling. To study the molecular mechanisms leading to deformation-induced ET B -R expression, we have cultured rat aortic smooth muscle cells (SMC) on flexible elastomers and, when grown to 7 0% confluence, periodically stretched them for 6 h (15% elongation, 0.5 Hz). The cells responded with an increase both in ET B -R mRNA (12-fold compared to control) and protein (4-fold).
Introduction
One of the most potent stimuli for the synthesis of endothelin-1 (ET-1) is a high level of circumferential stretch to which preferentially SMC but also endothelial cells are exposed to by an increase in blood pressure (1) . Besides its vasoconstrictor effect primarily mediated by the A type receptor (ET A -R), ET-1 has also been shown to be a potent co-mitogen for vascular smooth muscle cells (SMC, 2). Significant expression of the B type receptor (ET B -R) in these cells is only detectable upon exposure to cyclic stretch (3,4). However, activation of this receptor seems to contribute to changes in medial SMC phenotype that are typical for t he early phase of pressure-dependent remodeling of the vessel wall (3,4).
The endothelin system may thus act as a molecular switch between maintenance of vascular tone through ET A -R-mediated vasoconstriction and, in conditions of a prolonged supra-physiological increase in blood pressure, ETB-R-mediated adaptive remodeling. This process, when exaggerated, may play an important role e.g., in the manifestation of arterial hypertension (5), vein graft disease (6) or restenosis following angioplasty (7) that often are resistant to therapeutic interventions.
Preventing deformation-induced ET B -R expression in vascular SMC may thus constitute a feasible therapeutic option at the onset of these cardiovascular complications. To this end we have investigated the transcriptional control of ET B -R expression in vascular SMC exposed to cyclic stretch by using e.g., a novel nuclear run-on-based technique that directly analyzes the functional significance of a given transcription factor in expression of the gene product of interest ( run on based regulation of transcription analysis, ROBERTA). 
Decoy oligodeoxynucleotide (dODN) technique
Incubation of SMC with the double-stranded dODN (10 µM final concentration) for 4 h was done as described previously (10). Exposure of the cells to 2 different dODN was done consecutively with an exchange of the medium in-between. The sequence for the ATF dODN was exactly the same as that used for gel shift analysis except that the terminal 4 bases on either site of the molecule were linked by phosphorothioate esters for added stability.
Nuclear run-on analysis and ROBERTA
The RT-PCR-based nuclear run-on analysis was done as described previously (8).
Besides the de novo transcription of the ET B -R gene, transcription of GAPDH as an internal standard was analyzed, too. The run-on-based regulation of transcription assay (ROBERTA) is a modified nuclear run on-analysis. Prior to incubation with nucleotides (CTP, GTP and UTP, 2 mmol/L each) and the energy-regenerating system (creatinephosphate plus creatine-kinase) for specific RNA synthesis, nuclei (150 µL of suspension) were incubated at 0°C for 15 min with 0.5% Triton X-100, ATP (3 mmol/L) and the antibody against the transcription factor of interest. Thereafter, the nuclear runon procedure was started by the addition of the three ribonucleotides, creatinephosphate and creatine kinase, exactly as described (8). The amount as well as the type of antibody for effective inhibition of transcription had to be established for every transcription factor and antibody. In this study the final antibody concentrations were as follows: anti-c-Jun (20 µg/mL); anti-C/EBPβ (20 µg/mL); anti-STAT-1 (20 µg/mL) and anti-fibronectin (50 µg/mL).
Western blot analysis
Western blot analysis was performed according to standard procedures (10) using PVDF membranes (PALL Gelman, Dreieich, Germany). For detection o f ET B -R protein, a primary rabbit polyclonal antibody derived against a C -terminal peptide of the receptor 
Statistical analysis
Unless indicated otherwise, results are expressed as means ± SEM of n observations with cells obtained from different animals. One sample t test with two-sided P value or one-way analysis of variance followed by Dunnett post test were used where appropriate to determine statistical significant differences between the means and and/or the means and control with P<0.05 considered significant.
Results

Stretch-induced ET B -R expression is regulated at the transcriptional level
ET B -R mRNA and protein abundance were both enhanced in the cultured SMC after 6 h exposure to a level of cyclic stretch similar to the in vivo situation (12, Fig. 1 ). To evaluate whether the increase in ET B -R mRNA was due to transcriptional activation or enhanced mRNA stability, SMC were incubated with the transcriptional inhibitor actinomycin D (Fig. 2A) . In addition, a RT-PCR-based nuclear run-on assay was performed, demonstrating enhanced de novo synthesis of ET B -R mRNA in nuclei isolated from stretched SMC as compared to nuclei from SMC incubated under static conditions (Fig. 2B) .
Signal transduction pathways involved in stretch-induced ET B -R expression
Signal transduction pathways thought to be activated upon mechanical stimulation in vascular cells were targeted by using specific protein kinase inhibitors. Neither PD98059 (1 µM, 1 h pre-incubation), a specific inhibitor of MEK1 located up-stream of ERK/1/2, nor the protein kinase C inhibitor, Ro 31-8220 (1 µM, 1 h pre-incubation), affected deformation-induced ET B -R expression (n=4, not shown). In contrast, the ROCK inhibitor Y 27632 as well as SB 212190, an inhibitor of p38 MAPK, significantly attenuated ET B -R expression in response to cyclic stretch both at the mRNA and protein level (Fig. 3) . Co-incubation of the SMC with both inhibitors, however, did not result in a more pronounced inhibition (Fig. 3A) , indicating that both kinases are part of a common mechanotransduction pathway.
Transcription factors involved in stretch-induced ET B -R expression
According to TRANSFAC analysis (13), the promoter of the human ET B -R gene (GenBank accession no. AL139002) contains several consensus binding sites for the transcription factors ATF, AP-1 and C/EBP, the activation of which has been linked to the ROCK and/or p38 MAPK signaling pathways (14-17). Therefore, nuclear translocation of thes e transcription factors in SMC exposed to cyclic stretch was monitored by gel shift analysis. Whereas the transcription factor ATF appeared to be inert to cyclic stretch (not shown), both AP-1 and C/EBP abundance in the nucleus were transiently enhanced (maximum 1 h, not shown). Moreover, translocation of AP-1 as well as C/EBP was sensitive to both Y27632 and SB212190 (Fig. 4) . According to super-shift analysis, primarily the β-isoform of C/EBP appeared to be stretch-sensitive.
To confirm the involvement of AP -1 and C/EBPβ activation in stretch-induced ET B -R expression, 2 experimental approaches were chosen. First, SMC were pre-incubated for If this hypothesis holds true, p38-MAPK, besides its well documented ability to phosphorylate c -Jun, hence activate AP-1, must be able to activate C/EBP, too, and this has in fact been documented in other cell types (15, 22).
Transcriptional regulation of the ET B -R gene
The 
ROBERTA
At least in the case of C/EBP, this conclusion was supported by ROBERTA, a direct method for monitoring transcription factor activity in the nucleus. This method, which was devised on the basis of a previously published nuclear run-on assay (9), seems to 
